News | Ultrasound Imaging | September 15, 2023

The Kosmos ultrasound system now offers the most advanced feature set of any hand-carried device compatible with Apple iOS 

The Kosmos ultrasound system now offers the most advanced feature set of any hand-carried device compatible with Apple iOS

September 15, 2023 —EchoNous, a leader in transformative handheld point-of-care ultrasound solutions, announced a new advancement in its medical imaging technology. The acclaimed Kosmos system, known for its high-quality ultrasound performance and cutting-edge AI solutions, now provides advanced capabilities on compatible iOS tablets, empowering healthcare providers with increased accessibility and versatility. 

With this latest development, EchoNous takes another major step forward in revolutionizing point-of-care ultrasound by increasing access to its platform across multiple operating systems. Integrating the Kosmos system with compatible iOS tablets allows clinicians to harness the power of advanced medical imaging on some of the highest-performance tablets available. 

The Kosmos system is now available on three platforms, our own proprietary tablet as well as Android and iOS compatible tablets, offering the user flexibility to customize the system to suit their own preferences and clinical settings. 

"Our commitment to improving patient care by driving innovation and our refusal to compromise on quality has led us to this remarkable milestone," said Graham Cox, CEO of EchoNous. "By expanding the Kosmos system's capabilities to compatible iOS tablets, we aim to empower clinicians with greater flexibility and efficiency, thereby enhancing their ability to make critical decisions for their patients." 

  • The Kosmos system on iOS tablets maintains the same level of ultrasound performance and advanced AI technology for which EchoNous is well known. Some of the top features of the Kosmos iOS application include:
    High-end 2D Imaging 
  • M-Mode 
  • Color Doppler Imaging (CDI) 
  • Color Power Doppler (CPD) 
  • Pulsed Wave (PW) Doppler for both Lexsa (Linear) and Torso (Phased Array) probes 
  • Continuous Wave (CW) Doppler 
  • Tissue Doppler Imaging (TDI) 
  • Trio AI (Cardiac: Auto Guidance, Auto-Grading, Auto-Labeling) 
  • AI FAST (Abdominal: Auto-Labeling) 
  • Auto-Ejection Fraction (EF) calculation 
  • Auto-VTI Tracing 
  • DICOM SR for cardiac calculation 
  • Cardiac Calcs 
  • Vascular Calcs 
  • Post Exam Processing 

For more information: www.echonous.com 


Related Content

News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiology Business

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition ...

Time March 05, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — AS Software, a provider of specialty-focused ultrasound reporting solutions, has announced that the U.S ...

Time March 02, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
Subscribe Now